House Investigates Tenure Of FDA Medical Products Office Acting Head
This article was originally published in The Tan Sheet
Executive Summary
In a letter to FDA Commissioner Hamburg, Energy and Commerce Committee leaders say public information discrepancies raised questions about Leona Brenner-Gati’s status and “the circumstances surrounding her resignation.”
You may also be interested in...
FDA Mines Small Field Of Industry Candidates To Fill Executive Vacancies
Criteria for FDA’s leadership posts are extensive and the hiring process is long, but Richard Moscicki still believes industry and academics should consider applying. As more long-time officials retire, he says it is critical to fill open positions to allow for a “smooth transition over an extended period of time.”
FDA Mines Small Field Of Industry Candidates To Fill Executive Vacancies
Criteria for FDA’s leadership posts are extensive and the hiring process is long, but Richard Moscicki still believes industry and academics should consider applying. As more long-time officials retire, he says it is critical to fill open positions to allow for a “smooth transition over an extended period of time.”
FDA Mulls Another Makeover; Looking To Integrate Agency Functions
FDA Commissioner Hamburg has appointed 10 officials to come up with a plan to realign the agency, with the goal of moving toward a “specialized program-based model.”